Molecular Pathways Molecular Pathways : The Hedgehog Signaling Pathway in Cancer

The Hedgehog (Hh) signaling pathway regulates embryonic development and may be aberrantly activated in a wide variety of human cancers. Efforts to target pathogenic Hh signaling have steadily progressed from the laboratory to the clinic, and the recent approval of the Hh pathway inhibitor vismodegib for patients with advanced basal cell carcinoma represents an important milestone. On the other hand, Hh pathway antagonists have failed to show significant clinical activity in other solid tumors. The reasons for these negative results are not precisely understood, but it is possible that the impact of Hh pathway inhibition has not been adequately measured by the clinical endpoints used thus far or that aberrancies in Hh signal transduction limits the activity of currently available pathway antagonists. Further basic and correlative studies to better understand Hh signaling in human tumors and validate putative antitumormechanisms in the clinical settingmay ultimately improve the success of Hh pathway inhibition to other tumor types. Clin Cancer Res; 18(18); 4883–8. 2012 AACR.

[1]  R. Serra,et al.  Depletion of primary cilia in articular chondrocytes results in reduced Gli3 repressor to activator ratio, increased Hedgehog signaling, and symptoms of early osteoarthritis. , 2012, Osteoarthritis and cartilage.

[2]  M. Baccarani,et al.  Phase 1 Dose-Escalation Study of PF-04449913, An Oral Hedgehog (Hh) Inhibitor, in Patients with Select Hematologic Malignancies , 2011 .

[3]  S. Angers,et al.  Gli proteins in development and disease. , 2011, Annual review of cell and developmental biology.

[4]  A. Hauschild,et al.  CO14. A pivotal study evaluating efficacy and safety of the hedgehog pathway inhibitor (HPI) vismodegib (GDC-0449) in patients with locally advanced (la) or metastatic (m) basal cell carcinoma (BCC) , 2011 .

[5]  Zhou Zhu,et al.  Abstract 4504: PF-04449913, a small molecule inhibitor of Hedgehog signaling, is effective in inhibiting tumor growth in preclinical models , 2011 .

[6]  M. Kawamura,et al.  Abstract 2823: TAK-441, a novel investigational small molecule hedgehog pathway inhibitor for use in cancer therapy , 2011 .

[7]  N. Riobo,et al.  Heterotrimeric Gi Proteins Link Hedgehog Signaling to Activation of Rho Small GTPases to Promote Fibroblast Migration* , 2011, The Journal of Biological Chemistry.

[8]  C. Rudin,et al.  Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors , 2011, Clinical Cancer Research.

[9]  P. Beachy,et al.  Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector , 2010, Proceedings of the National Academy of Sciences.

[10]  Jun O. Liu,et al.  Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. , 2010, Cancer cell.

[11]  M. Warmuth,et al.  Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist. , 2010, ACS medicinal chemistry letters.

[12]  C. Iacobuzio-Donahue,et al.  Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. , 2010, Journal of the National Cancer Institute.

[13]  M. Kazanietz,et al.  Hedgehog proteins activate pro-angiogenic responses in endothelial cells through non-canonical signaling pathways , 2010, Cell cycle.

[14]  C. Rudin,et al.  Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. , 2009, The New England journal of medicine.

[15]  C. Rudin,et al.  Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma , 2009, Science.

[16]  A. Ruiz i Altaba,et al.  Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion , 2009, EMBO molecular medicine.

[17]  J. Reiter,et al.  Primary cilia can both mediate and suppress Hedgehog pathway–dependent tumorigenesis , 2009, Nature Medicine.

[18]  Mark G. F. Sun,et al.  Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade , 2009, Proceedings of the National Academy of Sciences.

[19]  John Calvin Reed,et al.  The Patched dependence receptor triggers apoptosis through a DRAL–caspase-9 complex , 2009, Nature Cell Biology.

[20]  A. Üren,et al.  GLI1 Is a Direct Transcriptional Target of EWS-FLI1 Oncoprotein* , 2009, Journal of Biological Chemistry.

[21]  M. Scott,et al.  Hedgehog signal transduction by Smoothened: Pharmacologic evidence for a 2-step activation process , 2009, Proceedings of the National Academy of Sciences.

[22]  Stuart L. Schreiber,et al.  A small molecule that binds Hedgehog and blocks its signaling in human cells , 2009, Nature chemical biology.

[23]  James R. Porter,et al.  Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists. , 2008, Journal of medicinal chemistry.

[24]  E. Epstein.  Basal cell carcinomas: attack of the hedgehog , 2008, Nature Reviews Cancer.

[25]  M. Warmuth,et al.  Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. , 2008, Cancer cell.

[26]  Dirk Troost,et al.  Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features , 2008, PloS one.

[27]  T. Triche,et al.  The EWS/FLI1 oncogenic transcription factor deregulates GLI1 , 2008, Oncogene.

[28]  Hua Tian,et al.  A paracrine requirement for hedgehog signalling in cancer , 2008, Nature.

[29]  A. Olivi,et al.  Cyclopamine‐Mediated Hedgehog Pathway Inhibition Depletes Stem‐Like Cancer Cells in Glioblastoma , 2007, Stem cells.

[30]  Monika Engelhardt,et al.  Essential role of stromally induced hedgehog signaling in B-cell malignancies , 2007, Nature Medicine.

[31]  T. Shimokawa,et al.  Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists , 2007, Proceedings of the National Academy of Sciences.

[32]  Barbara Stecca,et al.  Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways , 2007, Proceedings of the National Academy of Sciences.

[33]  C. Huff,et al.  Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma , 2007, Proceedings of the National Academy of Sciences.

[34]  C. Iacobuzio-Donahue,et al.  Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. , 2007, Cancer research.

[35]  G. Dontu,et al.  Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. , 2006, Cancer research.

[36]  P. Walsh.  Hedgehog signalling in prostate regeneration, neoplasia and metastasis. , 2005, The Journal of urology.

[37]  Yutaka Shimada,et al.  Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours , 2003, Nature.

[38]  Stephen B. Baylin,et al.  Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer , 2003, Nature.

[39]  Jussi Taipale,et al.  Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. , 2002, Genes & development.

[40]  P. Ingham,et al.  Hedgehog signaling in animal development: paradigms and principles. , 2001, Genes & development.

[41]  M. Nakafuku,et al.  Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling. , 1999, Development.

[42]  P. Beachy,et al.  Teratogen-mediated inhibition of target tissue response to Shh signaling. , 1998, Science.

[43]  A. Goldstein,et al.  Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. , 1997, American journal of medical genetics.

[44]  R. Myers,et al.  Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus Syndrome , 1996, Science.

[45]  Michael Dean,et al.  Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome , 1996, Cell.

[46]  C. Nüsslein-Volhard,et al.  Mutations affecting segment number and polarity in Drosophila , 1980, Nature.

[47]  R. Gorlin,et al.  Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. , 1960, The New England journal of medicine.

[48]  Tannishtha Reya,et al.  Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia , 2009, Nature.

[49]  David Hogg,et al.  Mutations in SUFU predispose to medulloblastoma , 2002, Nature Genetics.